120552-57-0 Usage
General Description
Cyclohexanecarboxaldehyde, 4-methoxy- (9CI) is a chemical compound with the molecular formula C8H10O2. It is a derivative of cyclohexanecarboxaldehyde, with a methoxy group (O-CH3) attached at the 4-position on the benzene ring. Cyclohexanecarboxaldehyde, 4-methoxy- (9CI) is used in organic synthesis and as an intermediate in the production of various industrial chemicals. It has a characteristic odor and is often used as a fragrance ingredient in perfumes and cosmetic products. Additionally, it has potential applications in pharmaceuticals and agrochemicals due to its versatile chemical structure and reactivity. However, like all chemical compounds, proper handling and disposal of cyclohexanecarboxaldehyde, 4-methoxy- (9CI) are necessary to prevent any adverse effects on human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 120552-57-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,5,5 and 2 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 120552-57:
(8*1)+(7*2)+(6*0)+(5*5)+(4*5)+(3*2)+(2*5)+(1*7)=90
90 % 10 = 0
So 120552-57-0 is a valid CAS Registry Number.
120552-57-0Relevant articles and documents
NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF
-
Paragraph 00152, (2020/12/01)
The invention provides compounds for inhibiting glucosylceramidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds.
3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
-
Paragraph 0869; 0871, (2019/03/08)
The present disclosure provides a compound of Formula (I′): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein R1, R2, Rx, X1, n, n1, and q are as defined herein, and methods of making and using same.
HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS AND COMBINATIONS THEREOF
-
Page/Page column 355, (2015/07/07)
Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds and combinations of such compounds and other therapeutic agents.
